Biomedical Engineering Reference
In-Depth Information
[38]
Korf-Klingebiel M, T Kempf, T Sauer, E Brinkmann, P Fischer, GP Meyer, A Ganser, H Drexler
and KC Wollert (2008). Bone marrow cells are a rich source of growth factors and cytokines: impli-
cations for cell therapy trials after myocardial infarction. European Heart Journal 29: 2851-2858.
[39]
Lim SY, DG Lee, P Sivakumaran, D Crombie, J Slavin, M Dottori, B Conley, M Denham,
J Leung, R Tee,
et al
. (2012).
In vivo
tissue engineering chamber supports human induced plu-
ripotent stem cell survival and rapid differentiation. Biochemical and Biophysical Research
Communications 422: 75-79.
[40]
Yoshida A, K Chitcholtan, JJ Evans, V Nock and SW Beasley (2012).
In vitro
tissue engineering
of smooth muscle sheets with peristalsis using a murine induced pluripotent stem cell line.
Journal of Pediatric Surgery 47: 329-335.
[41]
Uemura T, K Takamatsu, M Ikeda, M Okada, K Kazuki, Y Ikada and H Nakamura (2011).
A tissue-engineered bioabsorbable nerve conduit created by three-dimensional culture of induced
pluripotent stem cell-derived neurospheres. Bio-Medical Materials and Engineering 21: 333-339.
[42]
White K, NM Kane, G Milligan and AH Baker (2012). The role of miRNA in stem cell pluri-
potency and commitment to the vascular endothelial lineage. Microcirculation 19: 196-207.
[43]
Liu Z, DR Scannell, MB Eisen and R Tjian (2011). Control of embryonic stem cell lineage com-
mitment by core promoter factor, TAF3. Cell 146: 720-31.
[44]
Liang G, Y Yang, S Oh, JL Ong, C Zheng, J Ran, G Yin and D Zhou (2005). Ectopic osteoin-
duction and early degradation of recombinant human bone morphogenetic protein-2-loaded
porous beta-tricalcium phosphate in mice. Biomaterials 26: 4265-71.
[45]
Kuwahara K, JY Fang, Z Yang and B Han (2011). Enzymatic crosslinking and degradation of
gelatin as a switch for bone morphogenetic protein-2 activity. Tissue Engineering Part A 17:
2955-64.
[46]
Chan BY and CB Little (2012). The interaction of canonical bone morphogenetic protein- and
Wnt-signaling pathways may play an important role in regulating cartilage degradation in oste-
oarthritis. Arthritis Research and Therapy 14: 119.
[47]
Detmer K, TA Steele, MA Shoop and H Dannawi (1999). Lineage-restricted expression of bone
morphogenetic protein genes in human hematopoietic cell lines. Blood Cells, Molecules and
Diseases 25: 310-323.
[48]
Nelson BR, S Matsuhashi and F Lefcort (2002). Restricted neural epidermal growth factor-like
like 2 (NELL2) expression during muscle and neuronal differentiation. Mechanisms of
Development 119 (Suppl 1): S11-S19.
[49]
Horiuchi K, N Amizuka, S Takeshita, H Takamatsu, M Katsuura, H Ozawa, Y Toyama, LF
Bonewald and A Kudo (1999). Identification and characterization of a novel protein, periostin,
with restricted expression to periosteum and periodontal ligament and increased expression by
transforming growth factor beta. Journal of Bone and Mineral Research 14: 1239-1249.
[50]
Constam DB and EJ Robertson (1999). Regulation of bone morphogenetic protein activity by
pro domains and proprotein convertases. Journal of Cell Biology 144: 139-149.
[51]
Hillger F, G Herr, R Rudolph and E Schwarz (2005). Biophysical comparison of BMP-2,
ProBMP-2, and the free pro-peptide reveals stabilization of the pro-peptide by the mature
growth factor. Journal of Biological Chemistry 280: 14974-1480.
[52]
Elmasri H, E Ghelfi, CW Yu, S Traphagen, M Cernadas, H Cao, GP Shi, J Plutzky, M Sahin,
G Hotamisligil,
et al
. (2012). Endothelial cell-fatty acid binding protein 4 promotes angiogenesis:
role of stem cell factor/c-kit pathway. Angiogenesis 15: 457-468.
[53]
Iguchi H, T Mitsui, M Ishida, S Kanba and J Arita (2011). cAMP response element-binding
protein (CREB) is required for epidermal growth factor (EGF)-induced cell proliferation and
serum response element activation in neural stem cells isolated from the forebrain subventricu-
lar zone of adult mice. Endocrine Journal 58: 747-759.
[54]
Behnam K, ML Phillips, JD Silva, EJ Brochmann, ME Duarte and SS Murray (2005).
BMP binding peptide: a BMP-2 enhancing factor deduced from the sequence of native bovine
bone morphogenetic protein/non-collagenous protein. Journal of Orthopaedic Research 23:
175-180.
[55]
Lin X, PO Zamora, S Albright, JD Glass and LA Pena (2005). Multidomain synthetic peptide
B2A2 synergistically enhances BMP-2
in vitro
. Journal of Bone and Mineral Research 20:
693-703.
